RESMED INC (RMD)
Surgical & Medical Instruments & Apparatus · Surgical & Medical Instruments & Apparatus · NYSE
$230.65
+4.85%
Investingg Score
72.8 / 100
Buy
Business overview
- Gross margin of 61.1%
- Operating margin of 33.4%
- FCF margin of 29.2%
These high margins indicate strong pricing power and operational efficiency in the surgical and medical instruments industry.
Financial health
- Balance Sheet pillar score of 92 out of 100
- Risk pillar score of 100 out of 100
- FCF yield of 5%
These robust scores and positive free cash flow yield point to a solid financial foundation with minimal near-term solvency risks.
- Gross Margin
- 61.1%
- Operating Margin
- 33.4%
- Current Ratio
- 3.1x
- Debt / Equity
- 0.06
- Free Cash Flow (TTM)
- $1.6B
- Interest Coverage
- Data unavailable
Valuation
- P/E ratio of 22.11
- Forward P/E of 17.41
- EV to EBITDA of 15.6
These valuation multiples suggest the stock is reasonably priced relative to its earnings power and expected future profitability.
- P/E (TTM)
- 22.1x
- Forward P/E
- 17.4x
- Price / Sales
- 6.1x
- EV / EBITDA
- 15.6x
- FCF Yield
- 5.0%
Key risks
- Data unavailable for specific operational risks as the dataset lists zero risks.
- Uncertainty regarding whether historical revenue growth of 9.9% can be sustained.
- Technical RSI of 68.47 suggests potential short-term overbought conditions.
Market cap $33.3B · data as of 2026-08-19
Related stocks
Get the full interactive report
Technicals, earnings history, news, bull/base/bear scenarios, Ask the Stock, and more — free to start.
Analyze RMD with Investingg AINot investment advice. Investingg AI summarizes public data and AI-generated analysis for informational purposes only.